Rules-Based Medicine Awarded Phase II STTR Grant by U.S. Department of Defense.RBM RBM Roll Back Malaria (global partnership to reduce malaria) RBM Results Based Management RBM Reserve Bank of Malawi RBM Risk Based Maintenance RBM Reliability Based Maintenance RBM Reticular Basement Membrane RBM Radiation Belt Monitor to Apply Multi-Analyte Profiling to Determine Soldier Operational Readiness The capability of a unit/formation, ship, weapon system, or equipment to perform the missions or functions for which it is organized or designed. May be used in a general sense or to express a level or degree of readiness. Also called OR. See also combat readiness. Using Serum Biomarker Patterning AUSTIN, Texas -- Rules-Based Medicine, Inc. (RBM), the leading multiplexed biomarker testing laboratory for the life sciences industry, announced today that it has been awarded a Phase II Small Business Technology Transfer (STTR STTR Small Business Technology Transfer Program STTR Stator STTR Small Technology Transfer Innovation Research ) grant by the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. Department of Defense entitled "Rapid Assessment of Individual Soldier Operational Readiness." In partnership with Lawrence Livermore National Laboratories, Livermore, Calif., RBM will apply its Multi-Analyte Profiling (MAP) approach for determining biomarker patterns indicative of operational readiness for members of the armed forces. The two-year project, funded for $750,000, will test plasma samples collected from armed forces personnel as they recover from physical stress in their training environments. The awarding of the Phase II STTR grant follows RBM's successful completion of a previous project also conducted in conjunction with Lawrence Livermore National Labs funded by a $100,000 Phase I grant. "We anticipate that the results of this Phase II project will lead to the development of a powerful assessment tool further validating the broad applicability of RBM's Multi-Analyte Profiling approach," said Craig Benson, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Rules-Based Medicine. About Rules-Based Medicine Rules-Based Medicine is a biomarker testing laboratory that delivers high-quality, quantitative, multiplexed immunoassay Immunoassay An assay that quantifies antigen or antibody by immunochemical means. The antigen can be a relatively simple substance such as a drug, or a complex one such as a protein or a virus. data strictly as a service. RBM's multi-analyte profiles (MAPs) measure from several to hundreds of proteins in a small sample in multiple species and sample types. MAPs provide robust biomarker patterns for drug development, diagnostic, academic, consumer products and environmental applications. More information is located at www.rulesbasedmedicine.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion